Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2012 09:36 ET | Source: TrialAdvance, Inc

TrialAdvance, Inc. Establishes New Strategy Group Focused on Underrepresented Populations in Clinical Trials: Rebecca Budd to Head Group

CHICAGO, March 6, 2012 (GLOBE NEWSWIRE) -- Kathleen B. Drennan, president and CEO of TrialAdvance, Inc., announces the creation of a new strategy group called iDICT (Improving Disparities In Clinical...